Trials / Completed
CompletedNCT01248936
A Study of RO5185426 in Patients With Metastatic Melanoma
A SINGLE ARM, OPEN LABEL, EXPANDED ACCESS STUDY OF RG7204 IN PREVIOUSLY TREATED PATIENTS WITH METASTATIC MELANOMA
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 374 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, non-comparative, multicenter, expanded access study of RO5185426 in patients who have received prior systemic therapy for metastatic melanoma and who have no other satisfactory treatment options.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RO5185426 |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2010-11-25
- Last updated
- 2016-08-12
- Results posted
- 2016-02-11
Locations
28 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01248936. Inclusion in this directory is not an endorsement.